B. ARSLAN Et Al. , "Analyze of Risk Factors Affecting the Outcomes of Docetaxel-prednisone Combination in the Treatment of Metastatic Castration-resistant Prostate Cancer," British Journal of Medicine and Medical Research , vol.15, no.5, pp.1-8, 2016
ARSLAN, B. Et Al. 2016. Analyze of Risk Factors Affecting the Outcomes of Docetaxel-prednisone Combination in the Treatment of Metastatic Castration-resistant Prostate Cancer. British Journal of Medicine and Medical Research , vol.15, no.5 , 1-8.
ARSLAN, B., AKBULUT, M. F., ONUK, Ö., HAZAR, A. İ., ÖZKAN, A., GEZMİŞ, C. T., ... ÇETİN, B.(2016). Analyze of Risk Factors Affecting the Outcomes of Docetaxel-prednisone Combination in the Treatment of Metastatic Castration-resistant Prostate Cancer. British Journal of Medicine and Medical Research , vol.15, no.5, 1-8.
ARSLAN, BURAK Et Al. "Analyze of Risk Factors Affecting the Outcomes of Docetaxel-prednisone Combination in the Treatment of Metastatic Castration-resistant Prostate Cancer," British Journal of Medicine and Medical Research , vol.15, no.5, 1-8, 2016
ARSLAN, BURAK Et Al. "Analyze of Risk Factors Affecting the Outcomes of Docetaxel-prednisone Combination in the Treatment of Metastatic Castration-resistant Prostate Cancer." British Journal of Medicine and Medical Research , vol.15, no.5, pp.1-8, 2016
ARSLAN, B. Et Al. (2016) . "Analyze of Risk Factors Affecting the Outcomes of Docetaxel-prednisone Combination in the Treatment of Metastatic Castration-resistant Prostate Cancer." British Journal of Medicine and Medical Research , vol.15, no.5, pp.1-8.
@article{article, author={BURAK ARSLAN Et Al. }, title={Analyze of Risk Factors Affecting the Outcomes of Docetaxel-prednisone Combination in the Treatment of Metastatic Castration-resistant Prostate Cancer}, journal={British Journal of Medicine and Medical Research}, year=2016, pages={1-8} }